Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
225
-
Total 13F shares, excl. options
-
73.8M
-
Shares change
-
-2.19M
-
Total reported value, excl. options
-
$4.71B
-
Value change
-
-$155M
-
Put/Call ratio
-
2.51
-
Number of buys
-
142
-
Number of sells
-
-92
-
Price
-
$63.83
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q3 2019
287 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q3 2019.
Guardant Health, Inc. - Common Stock (GH) has 225 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.8M shares
of 124M outstanding shares and own 59.58% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (23M shares), MORGAN STANLEY (5.42M shares), VK Services, LLC (4.64M shares), JENNISON ASSOCIATES LLC (3.38M shares), VANGUARD GROUP INC (3.36M shares), SC US (TTGP), LTD. (3.12M shares), VIKING GLOBAL INVESTORS LP (2.87M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.02M shares), JPMORGAN CHASE & CO (1.97M shares), and BlackRock Inc. (1.94M shares).
This table shows the top 225 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.